Nano-Drug Delivery Systems Based on Natural Products

References

• Khan IA, Smillie T. Implementing a “Quality by Design” Approach to Assure the Safety and Integrity of Botanical Dietary Supplements. J Nat Prod. 2012;75(9):1665–1673. doi:10.1021/np300434j
   PubMed Web of Science ®Google Scholar
• Mehta P, Shah R, Lohidasan S, Mahadik KR. Pharmacokinetic profile of phytoconstituent(s) isolated from medicinal plants-A comprehensive review. J Tradit Complement Med. 2015;5(4):207–227. doi:10.1016/j.jtcme.2014.11.041
   PubMedGoogle Scholar
• Rodrigues T, Reker D, Schneider P, Schneider G. Counting on natural products for drug design. Nat Chem. 2016;8(6):531–541. doi:10.1038/nchem.2479
   PubMed Web of Science ®Google Scholar
• Vanti G. Recent strategies in nanodelivery systems for natural products: a review. Environ Chem Lett. 2021;19(6):4311–4326. doi:10.1007/s10311-021-01276-x
   Web of Science ®Google Scholar
• Beutler JA. Natural Products as a Foundation for Drug Discovery. Curr Protoc Pharmacol. 2009;46:9.11.1–9.11.21. doi:10.1002/0471141755.ph0911s46
   PubMedGoogle Scholar
• Watkins R, Wu L, Zhang C, Davis RM, Xu B. Natural product-based nanomedicine: recent advances and issues. Int J Nanomed. 2015;10:6055–6074. doi:10.2147/IJN.S92162
   PubMed Web of Science ®Google Scholar
• Patra JK, Das G, Fraceto LF, et al. Nano based drug delivery systems: recent developments and future prospects. J Nanobiotechnol. 2018;16(1):71. doi:10.1186/s12951-018-0392-8
   PubMed Web of Science ®Google Scholar
• Martinho N, Damgé C, Reis CP. Recent Advances in Drug Delivery Systems. J Biomater Nanobiotechnol. 2011;02(05):510–526. doi:10.4236/jbnb.2011.225062
   Google Scholar
• Jahangirian H, Lemraski EG, Webster TJ, Rafiee-Moghaddam R, Abdollahi Y. A review of drug delivery systems based on nanotechnology and green chemistry: green nanomedicine. Int J Nanomed. 2017;12:2957–2978. doi:10.2147/IJN.S127683
   PubMed Web of Science ®Google Scholar
• Bonifácio BV, Silva PB, Ramos MADS, Negri KMS, Bauab TM, Chorilli M. Nanotechnology-based drug delivery systems and herbal medicines: a review. Int J Nanomed. 2014;9:1–15. doi:10.2147/IJN.S52634
   PubMed Web of Science ®Google Scholar
• Liu Z, Tabakman S, Welsher K, Dai H. Carbon Nanotubes in Biology and Medicine: in vitro and in vivo Detection, Imaging and Drug Delivery. Nano Res. 2009;2(2):85–120. doi:10.1007/s12274-009-9009-8
   PubMed Web of Science ®Google Scholar
• Razzacki SZ, Thwar PK, Yang M, Ugaz VM, Burns MA. Integrated microsystems for controlled drug delivery. Adv Drug Deliv Rev. 2004;56(2):185–198. doi:10.1016/j.addr.2003.08.012
   PubMed Web of Science ®Google Scholar
• Lam PL, Wong WY, Bian Z, Chui CH, Gambari R. Recent advances in green nanoparticulate systems for drug delivery: efficient delivery and safety concern. Nanomed. 2017;12(4):357–385. doi:10.2217/nnm-2016-0305
   PubMed Web of Science ®Google Scholar
• Rudramurthy GR, Swamy MK, Sinniah UR, Ghasemzadeh A. Nanoparticles: alternatives Against Drug-Resistant Pathogenic Microbes. Mol. 2016;21(7):836.
   PubMed Web of Science ®Google Scholar
• Saka R, Chella N. Nanotechnology for delivery of natural therapeutic substances: a review. Environ Chem Lett. 2021;19(2):1097–1106. doi:10.1007/s10311-020-01103-9
   Web of Science ®Google Scholar
• Jain H, Chella N. Methods to improve the solubility of therapeutical natural products: a review. Environ Chem Lett. 2021;19(1):111–121. doi:10.1007/s10311-020-01082-x
   Web of Science ®Google Scholar
• Paroha S, Dewangan RP, Dubey RD, Sahoo PK. Conventional and nanomaterial-based techniques to increase the bioavailability of therapeutic natural products: a review. Environ Chem Lett. 2020;18(6):1767–1778. doi:10.1007/s10311-020-01038-1
   Web of Science ®Google Scholar
• Ita KB. Prodrugs for transdermal drug delivery – trends and challenges. J Drug Target. 2016;24(8):671–678. doi:10.3109/1061186X.2016.1154562
   PubMed Web of Science ®Google Scholar
• Fang JY, Leu YL. Prodrug strategy for enhancing drug delivery via skin. Curr Drug Discov Technol. 2006;3(3):211–224. doi:10.2174/157016306780136772
   PubMedGoogle Scholar
• Shi X, Sun K, Baker JR. Spontaneous Formation of Functionalized Dendrimer-Stabilized Gold Nanoparticles. J Phys Chem C Nanomater Interfaces. 2009;112(22):8251–8258. doi:10.1021/jp801293a
   PubMed Web of Science ®Google Scholar
• Park SH, Oh SG, Mun JY, Han SS. Loading of gold nanoparticles inside the DPPC bilayers of liposome and their effects on membrane fluidities. Colloids Surf B Biointerfaces. 2006;48(2):112–118. doi:10.1016/j.colsurfb.2006.01.006
   PubMed Web of Science ®Google Scholar
• Qiao L, Han M, Gao S, et al. Research progress on nanotechnology for delivery of active ingredients from traditional Chinese medicines. J Mater Chem B. 2020;8(30):6333–6351. doi:10.1039/D0TB01260B
   PubMed Web of Science ®Google Scholar
• Ashley EA. Towards precision medicine. Nat Rev Genet. 2016;17(9):507–522. doi:10.1038/nrg.2016.86
   PubMed Web of Science ®Google Scholar
• Muro S. Challenges in design and characterization of ligand-targeted drug delivery systems. J Control Release off J Control Release Soc. 2012;164(2):125–137. doi:10.1016/j.jconrel.2012.05.052
   PubMed Web of Science ®Google Scholar
• Srinivasarao M, Galliford CV, Low PS. Principles in the design of ligand-targeted cancer therapeutics and imaging agents. Nat Rev Drug Discov. 2015;14(3):203–219. doi:10.1038/nrd4519
   PubMed Web of Science ®Google Scholar
• Péczka N, Orgován Z, Ábrányi-Balogh P, Keserű GM. Electrophilic warheads in covalent drug discovery: an overview. Expert Opin Drug Discov. 2022;17(4):413–422. doi:10.1080/17460441.2022.2034783
   PubMed Web of Science ®Google Scholar
• Srinivasarao M, Low PS. Ligand-Targeted Drug Delivery. Chem Rev. 2017;117(19):12133–12164. doi:10.1021/acs.chemrev.7b00013
   PubMed Web of Science ®Google Scholar
• Li Y, Chen M, Yao B, et al. Transferrin receptor-targeted redox/pH-sensitive podophyllotoxin prodrug micelles for multidrug-resistant breast cancer therapy. J Mater Chem B. 2019;7(38):5814–5824. doi:10.1039/C9TB00651F
   PubMed Web of Science ®Google Scholar
• Van Heertum RL, Scarimbolo R, Ford R, Berdougo E, O’Neal M. Companion diagnostics and molecular imaging-enhanced approaches for oncology clinical trials. Drug Des Devel Ther. 2015;9:5215–5223. doi:10.2147/DDDT.S87561
   PubMed Web of Science ®Google Scholar
• Maurer AH, Elsinga P, Fanti S, Nguyen B, Oyen WJG, Weber WA. Imaging the folate receptor on cancer cells with 99mTc-etarfolatide: properties, clinical use, and future potential of folate receptor imaging. J Nucl Med off Publ Soc Nucl Med. 2014;55(5):701–704.
   PubMed Web of Science ®Google Scholar
• Farkas R, Siwowska K, Ametamey SM, Schibli R, van der Meulen NP, Müller C. 64Cu- and 68Ga-Based PET Imaging of Folate Receptor-Positive Tumors: development and Evaluation of an Albumin-Binding NODAGA−Folate. Mol Pharm. 2016;13(6):1979–1987. doi:10.1021/acs.molpharmaceut.6b00143
   PubMedGoogle Scholar
• Fani M, Tamma ML, Nicolas GP, et al. In Vivo Imaging of Folate Receptor Positive Tumor Xenografts Using Novel 68Ga-NODAGA-Folate Conjugates. Mol Pharm. 2012;9(5):1136–1145. doi:10.1021/mp200418f
   PubMedGoogle Scholar
• Müller C, Schibli R. Folic Acid Conjugates for Nuclear Imaging of Folate Receptor–Positive Cancer. J Nucl Med off Publ Soc Nucl Med. 2011;52(1):1–4.
   PubMed Web of Science ®Google Scholar
• Jin SE, Jin HE, Hong SS. Targeted delivery system of nanobiomaterials in anticancer therapy: from cells to clinics. BioMed Res Int. 2014;2014:814208. doi:10.1155/2014/814208
   PubMed Web of Science ®Google Scholar
• Scaranti M, Cojocaru E, Banerjee S, Banerji U. Exploiting the folate receptor α in oncology. Nat Rev Clin Oncol. 2020;17(6):349–359. doi:10.1038/s41571-020-0339-5
   PubMed Web of Science ®Google Scholar
• Li-chao SUN, Shu-ying LI, Feng-zhong W, Feng-jiao XIN. Research Progresses in the Synthetic Biology of Terpenoids. Biotechnol Bull. 2017;33(1):64.
   Google Scholar
• Lage H, Duarte N, Coburger C, Hilgeroth A, Ferreira MJU. Antitumor activity of terpenoids against classical and atypical multidrug resistant cancer cells. Phytomedicine. 2010;17(6):441–448. doi:10.1016/j.phymed.2009.07.009
   PubMed Web of Science ®Google Scholar
• Ge J, Liu Z, Zhong Z, et al. Natural terpenoids with anti-inflammatory activities: potential leads for anti-inflammatory drug discovery. Bioorg Chem. 2022;124:105817. doi:10.1016/j.bioorg.2022.105817
   PubMed Web of Science ®Google Scholar
• Yamaguchi T. Antibacterial effect of the combination of terpenoids. Arch Microbiol. 2022;204(8):520. doi:10.1007/s00203-022-03142-y
   PubMed Web of Science ®Google Scholar
• Lin LT, Chung CY, Hsu WC, et al. Saikosaponin b2 is a Naturally Occurring Terpenoid That Efficiently Inhibits Hepatitis C Virus Entry. J Hepatol. 2015;62(3):541–548. doi:10.1016/j.jhep.2014.10.040
   PubMed Web of Science ®Google Scholar
• Abdul Ghani MA, Ugusman A, Latip J, Zainalabidin S. Role of Terpenophenolics in Modulating Inflammation and Apoptosis in Cardiovascular Diseases: a Review. Int J Mol Sci. 2023;24(6):5339. doi:10.3390/ijms24065339
   PubMed Web of Science ®Google Scholar
• Gao J, Zhang Y, Liu X, Wu X, Huang L, Gao W. Triptolide: pharmacological spectrum, biosynthesis, chemical synthesis and derivatives. Theranostics. 2021;11(15):7199–7221. doi:10.7150/thno.57745
   PubMed Web of Science ®Google Scholar
• Xu H, Liu B. Triptolide-targeted delivery methods. Eur J Med Chem. 2019;164:342–351. doi:10.1016/j.ejmech.2018.12.058
   PubMed Web of Science ®Google Scholar
• Zhang YQ, Shen Y, Liao MM, et al. Galactosylated chitosan triptolide nanoparticles for overcoming hepatocellular carcinoma: enhanced therapeutic efficacy, low toxicity, and validated network regulatory mechanisms. Nanomedicine. 2019;15(1):86–97. doi:10.1016/j.nano.2018.09.002
   PubMed Web of Science ®Google Scholar
• Huang C, Zeng T, Li J, et al. Folate Receptor-Mediated Renal-Targeting Nanoplatform for the Specific Delivery of Triptolide to Treat Renal Ischemia/Reperfusion Injury. ACS Biomater Sci Eng. 2019;5(6):2877–2886. doi:10.1021/acsbiomaterials.9b00119
   PubMed Web of Science ®Google Scholar
• Qian T, Cai Z, Wong RNS, Mak NK, Jiang ZH. In vivo rat metabolism and pharmacokinetic studies of ginsenoside Rg3. J Chromatogr B. 2005;816(1):223–232. doi:10.1016/j.jchromb.2004.11.036
   PubMed Web of Science ®Google Scholar
• Xu QF, Fang XL, Chen DF. Pharmacokinetics and bioavailability of ginsenoside Rb1 and Rg1 from Panax notoginseng in rats. J Ethnopharmacol. 2003;84(2):187–192. doi:10.1016/S0378-8741(02)00317-3
   PubMed Web of Science ®Google Scholar
• Kim H, Lee JH, Kim JE, et al. Micro-/nano-sized delivery systems of ginsenosides for improved systemic bioavailability. J Ginseng Res. 2018;42(3):361–369. doi:10.1016/j.jgr.2017.12.003
   PubMed Web of Science ®Google Scholar
• Zhang J, Jiang Y, Li Y, et al. Micelles modified with a chitosan-derived homing peptide for targeted intracellular delivery of ginsenoside compound K to liver cancer cells. Carbohydr Polym. 2020;230:115576. doi:10.1016/j.carbpol.2019.115576
   PubMed Web of Science ®Google Scholar
• Winkel-Shirley B. Flavonoid biosynthesis. A colorful model for genetics, biochemistry, cell biology, and biotechnology. Plant Physiol. 2001;126(2):485–493. doi:10.1104/pp.126.2.485
   PubMed Web of Science ®Google Scholar
• Selvakumar P, Badgeley A, Murphy P, et al. Flavonoids and Other Polyphenols Act as Epigenetic Modifiers in Breast Cancer. Nutrients. 2020;12(3):761. doi:10.3390/nu12030761
   PubMed Web of Science ®Google Scholar
• Fernandes I, Pérez-Gregorio R, Soares S, Mateus N, De Freitas V. Wine Flavonoids in Health and Disease Prevention. Mol. 2017;22(2):292.
   PubMed Web of Science ®Google Scholar
• Amawi H, Ashby CR, Tiwari AK. Cancer chemoprevention through dietary flavonoids: what’s limiting? Chin J Cancer. 2017;36(1):50. doi:10.1186/s40880-017-0217-4
   PubMedGoogle Scholar
• Gao S, Hu M. Bioavailability challenges associated with development of anti-cancer phenolics. Mini Rev Med Chem. 2010;10(6):550–567. doi:10.2174/138955710791384081
   PubMed Web of Science ®Google Scholar
• Khan H, Ullah H, Martorell M, et al. Flavonoids nanoparticles in cancer: treatment, prevention and clinical prospects. Semin Cancer Biol. 2021;69:200–211. doi:10.1016/j.semcancer.2019.07.023
   PubMed Web of Science ®Google Scholar
• Aiello P, Consalvi S, Poce G, et al. Dietary flavonoids: nano delivery and nanoparticles for cancer therapy. Semin Cancer Biol. 2021;69:150–165. doi:10.1016/j.semcancer.2019.08.029
   PubMed Web of Science ®Google Scholar
• Zhou Z, Ma J. Gambogic acid suppresses colon cancer cell activity in vitro. Exp Ther Med. 2019;18(4):2917–2923. doi:10.3892/etm.2019.7912
   PubMed Web of Science ®Google Scholar
• Lin D, Lin X, He T, Xie G. Gambogic Acid Inhibits the Progression of Gastric Cancer via circRNA_ASAP2/miR-33a-5p/CDK7 Axis. Cancer Manag Res. 2020;12:9221–9233. doi:10.2147/CMAR.S269768
   PubMed Web of Science ®Google Scholar
• Wang H, Zhao Z, Lei S, et al. Gambogic acid induces autophagy and combines synergistically with chloroquine to suppress pancreatic cancer by increasing the accumulation of reactive oxygen species. Cancer Cell Int. 2019;19:7. doi:10.1186/s12935-018-0705-x
   PubMed Web of Science ®Google Scholar
• Wang Y, Liang X, Tong R, et al. Gambogic Acid-Loaded Polymeric Micelles for Improved Therapeutic Effect in Breast Cancer. J Biomed Nanotechnol. 2018;14(10):1695–1704. doi:10.1166/jbn.2018.2626
   PubMed Web of Science ®Google Scholar
• Li M, Su F, Zhu M, et al. Research Progress in the Field of Gambogic Acid and Its Derivatives as Antineoplastic Drugs. Mol. 2022;27(9):2937.
   PubMed Web of Science ®Google Scholar
• Wang X, Chen W. Gambogic acid is a novel anti-cancer agent that inhibits cell proliferation, angiogenesis and metastasis. Anticancer Agents Med Chem. 2012;12(8):994–1000. doi:10.2174/187152012802650066
   PubMed Web of Science ®Google Scholar
• Xu W, Wang H, Dong L, et al. Hyaluronic acid-decorated redox-sensitive chitosan micelles for tumor-specific intracellular delivery of gambogic acid. Int J Nanomed. 2019;14:4649–4666. doi:10.2147/IJN.S201110
   PubMed Web of Science ®Google Scholar
• Peng Y, Zhao FZ, Guo CS, et al. Effects and Mechanism of Baicalin on Apoptosis of Cervical Cancer HeLa Cells In-vitro. Iran J Pharm Res IJPR. 2015;14(1):251–261.
   PubMed Web of Science ®Google Scholar
• Mei ZQ, Wang S, Zhang H, et al. The combination of baicalin and baicalein enhances apoptosis via the ERK/p38 MAPK pathway in human breast cancer cells. Acta Pharmacol Sin. 2009;30(12):1648–1658. doi:10.1038/aps.2009.166
   PubMed Web of Science ®Google Scholar
• Gao C, Zhou Y, Li H, et al. Antitumor effects of baicalin on ovarian cancer cells through induction of cell apoptosis and inhibition of cell migration in vitro. Mol Med Rep. 2017;16(6):8729–8734. doi:10.3892/mmr.2017.7757
   PubMed Web of Science ®Google Scholar
• Meng F, Liu F, Lan M, et al. Preparation and evaluation of folate-modified albumin baicalin-loaded nanoparticles for the targeted treatment of breast cancer. J Drug Deliv Sci Technol. 2021;65:102603. doi:10.1016/j.jddst.2021.102603
   Web of Science ®Google Scholar
• Li X, Li S, Ma C, Li T, Yang L. Preparation of baicalin-loaded ligand-modified nanoparticles for nose-to-brain delivery for neuroprotection in cerebral ischemia. Drug Deliv. 2022;29(1):1282–1298. doi:10.1080/10717544.2022.2064564
   PubMed Web of Science ®Google Scholar
• Zhang Z, Qiu C, Li X, et al. Advances in research on interactions between polyphenols and biology-based nano-delivery systems and their applications in improving the bioavailability of polyphenols. Trends Food Sci Technol. 2021;116:492–500. doi:10.1016/j.tifs.2021.08.009
   Web of Science ®Google Scholar
• Kostić AŽ, Milinčić DD, Gašić UM, et al. Polyphenolic profile and antioxidant properties of bee-collected pollen from sunflower (Helianthus annuus L.) plant. LWT. 2019;112:108244. doi:10.1016/j.lwt.2019.06.011
   Web of Science ®Google Scholar
• Scalbert A, Johnson IT, Saltmarsh M. Polyphenols: antioxidants and beyond. Am J Clin Nutr. 2005;81(1):215S–217S. doi:10.1093/ajcn/81.1.215S
   PubMed Web of Science ®Google Scholar
• Davatgaran-Taghipour Y, Masoomzadeh S, Farzaei MH, et al. Polyphenol nanoformulations for cancer therapy: experimental evidence and clinical perspective. Int J Nanomed. 2017;12:2689–2702. doi:10.2147/IJN.S131973
   PubMed Web of Science ®Google Scholar
• Ignat I, Radu DG, Volf I, Pag AI, Popa VI. Antioxidant and antibacterial activities of some natural polyphenol. Cellulose Chem Technol. 2013;47(5–6):387–399.
   Web of Science ®Google Scholar
• Yahfoufi N, Alsadi N, Jambi M, Matar C. The Immunomodulatory and Anti-Inflammatory Role of Polyphenols. Nutrients. 2018;10(11):1618. doi:10.3390/nu10111618
   PubMed Web of Science ®Google Scholar
• Zhao C, Wan X, Zhou S, Cao H. Natural Polyphenols: a Potential Therapeutic Approach to Hypoglycemia. eFood. 2020;1(2):107–118. doi:10.2991/efood.k.200302.001
   Google Scholar
• Kumar Vivekanandhan D, Ranjan Prasad Verma P, Kumar Singh S. Emerging Technologies for Improving Bioavailability of Polyphenols. Curr Nutr Food Sci. 2016;12(1):12–22. doi:10.2174/1573401311666151015213704
   Google Scholar
• Han Y, Zhou J, Hu Y, et al. Polyphenol-Based Nanoparticles for Intracellular Protein Delivery via Competing Supramolecular Interactions. ACS Nano. 2020;14(10):12972–12981. doi:10.1021/acsnano.0c04197
   PubMed Web of Science ®Google Scholar
• Neethirajan S, Jayas DS. Nanotechnology for the Food and Bioprocessing Industries. Food Bioprocess Technol. 2011;4(1):39–47. doi:10.1007/s11947-010-0328-2
   PubMed Web of Science ®Google Scholar
• Gowd V, Kanika JC, et al. Resveratrol and resveratrol nano-delivery systems in the treatment of inflammatory bowel disease. J Nutr Biochem. 2022;109:109101. doi:10.1016/j.jnutbio.2022.109101
   PubMed Web of Science ®Google Scholar
• Liang M, Guo M, Saw PE, Yao Y. Fully Natural Lecithin Encapsulated Nano-Resveratrol for Anti-Cancer Therapy. Int J Nanomed. 2022;17:2069–2078. doi:10.2147/IJN.S362418
   PubMed Web of Science ®Google Scholar
• Jhaveri A, Deshpande P, Pattni B, Torchilin V. Transferrin-targeted, resveratrol-loaded liposomes for the treatment of glioblastoma. J Control Release. 2018;277:89–101. doi:10.1016/j.jconrel.2018.03.006
   PubMed Web of Science ®Google Scholar
• Naksuriya O, Okonogi S. Comparison and combination effects on antioxidant power of curcumin with gallic acid, ascorbic acid, and xanthone. Drug Discov Ther. 2015;9(2):136–141. doi:10.5582/ddt.2015.01013
   PubMedGoogle Scholar
• Vallianou NG, Evangelopoulos A, Schizas N, Kazazis C. Potential anticancer properties and mechanisms of action of curcumin. Anticancer Res. 2015;35(2):645–651.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Xia Q, Li Y, et al. CD44 Assists the Topical Anti-Psoriatic Efficacy of Curcumin-Loaded Hyaluronan-Modified Ethosomes: a New Strategy for Clustering Drug in Inflammatory Skin. Theranostics. 2019;9(1):48. doi:10.7150/thno.29715
   PubMed Web of Science ®Google Scholar
• Yan Y, Li X, Zhang C, Lv L, Gao B, Li M. Research Progress on Antibacterial Activities and Mechanisms of Natural Alkaloids: a Review. Antibiot Basel Switz. 2021;10(3):318.
   PubMed Web of Science ®Google Scholar
• Qing ZX, Huang JL, Yang XY, et al. Anticancer and Reversing Multidrug Resistance Activities of Natural Isoquinoline Alkaloids and their Structure-activity Relationship. Curr Med Chem. 2018;25(38):5088–5114. doi:10.2174/0929867324666170920125135
   PubMed Web of Science ®Google Scholar
• Gorpenchenko TY, Grigorchuk VP, Bulgakov DV, Tchernoded GK, Bulgakov VP. Tempo-Spatial Pattern of Stepharine Accumulation in Stephania Glabra Morphogenic Tissues. Int J Mol Sci. 2019;20(4):808. doi:10.3390/ijms20040808
   PubMed Web of Science ®Google Scholar
• Souza CRM, Bezerra WP, Souto JT. Marine Alkaloids with Anti-Inflammatory Activity: current Knowledge and Future Perspectives. Mar Drugs. 2020;18(3):147. doi:10.3390/md18030147
   PubMed Web of Science ®Google Scholar
• Ma X, Zhou J, Zhang CX, et al. Modulation of drug-resistant membrane and apoptosis proteins of breast cancer stem cells by targeting berberine liposomes. Biomaterials. 2013;34(18):4452–4465. doi:10.1016/j.biomaterials.2013.02.066
   PubMed Web of Science ®Google Scholar
• Majidzadeh H, Araj-Khodaei M, Ghaffari M, Torbati M, Ezzati Nazhad Dolatabadi J, Hamblin MR. Nano-based delivery systems for berberine: a modern anti-cancer herbal medicine. Colloids Surf B Biointerfaces. 2020;194:111188. doi:10.1016/j.colsurfb.2020.111188
   PubMed Web of Science ®Google Scholar
• Bregoli L, Movia D, Gavigan-Imedio JD, Lysaght J, Reynolds J, Prina-Mello A. Nanomedicine applied to translational oncology: a future perspective on cancer treatment. Nanomedicine. 2016;12(1):81–103. doi:10.1016/j.nano.2015.08.006
   PubMed Web of Science ®Google Scholar
• Jacob J, Haponiuk JT, Thomas S, Gopi S. Biopolymer based nanomaterials in drug delivery systems: a review. Mater Today Chem. 2018;9:43–55. doi:10.1016/j.mtchem.2018.05.002
   Web of Science ®Google Scholar
• Ingle SG, Pai RV, Monpara JD, Vavia PR. Liposils: an effective strategy for stabilizing Paclitaxel loaded liposomes by surface coating with silica. Eur J Pharm Sci off J Eur Fed Pharm Sci. 2018;122:51–63.
   PubMed Web of Science ®Google Scholar
• Wang F, Porter M, Konstantopoulos A, Zhang P, Cui H. Preclinical development of drug delivery systems for paclitaxel-based cancer chemotherapy. J Control Release off J Control Release Soc. 2017;267:100–118. doi:10.1016/j.jconrel.2017.09.026
   PubMed Web of Science ®Google Scholar
• Geisler JP, Linnemeier GC, Thomas AJ, Manahan KJ. Extreme drug resistance is common after prior exposure to paclitaxel. Gynecol Oncol. 2007;106(3):538–540. doi:10.1016/j.ygyno.2007.05.002
   PubMed Web of Science ®Google Scholar
• Ganta S, Amiji M. Coadministration of Paclitaxel and curcumin in nanoemulsion formulations to overcome multidrug resistance in tumor cells. Mol Pharm. 2009;6(3):928–939. doi:10.1021/mp800240j
   PubMed Web of Science ®Google Scholar
• Li T, Yu P, Chen Y, et al. N-acetylgalactosamine-decorated nanoliposomes for targeted delivery of paclitaxel to hepatocellular carcinoma. Eur J Med Chem. 2021;222:113605. doi:10.1016/j.ejmech.2021.113605
   PubMed Web of Science ®Google Scholar
• Khoshnejad M, Parhiz H, Shuvaev VV, Dmochowski IJ, Muzykantov VR. Ferritin-based drug delivery systems: hybrid nanocarriers for vascular immunotargeting. J Control Release off J Control Release Soc. 2018;282:13–24. doi:10.1016/j.jconrel.2018.02.042
   PubMed Web of Science ®Google Scholar
• Liang M, Fan K, Zhou M, et al. H-ferritin-nanocaged doxorubicin nanoparticles specifically target and kill tumors with a single-dose injection. Proc Natl Acad Sci U S A. 2014;111(41):14900–14905. doi:10.1073/pnas.1407808111
   PubMed Web of Science ®Google Scholar
• Fan K, Jia X, Zhou M, et al. Ferritin Nanocarrier Traverses the Blood Brain Barrier and Kills Glioma. ACS Nano. 2018;12(5):4105–4115. doi:10.1021/acsnano.7b06969
   PubMed Web of Science ®Google Scholar
• Pandolfi L, Bellini M, Vanna R, et al. H-Ferritin Enriches the Curcumin Uptake and Improves the Therapeutic Efficacy in Triple Negative Breast Cancer Cells. Biomacromolecules. 2017;18(10):3318–3330. doi:10.1021/acs.biomac.7b00974
   PubMed Web of Science ®Google Scholar
• Ma Y, Li R, Dong Y, et al. tLyP-1 Peptide Functionalized Human H Chain Ferritin for Targeted Delivery of Paclitaxel. Int J Nanomed. 2021;16:789. doi:10.2147/IJN.S289005
   PubMed Web of Science ®Google Scholar
• Yadav S, Sharma AK, Kumar P. Nanoscale Self-Assembly for Therapeutic Delivery. Front Bioeng Biotechnol. 2020;8:127. doi:10.3389/fbioe.2020.00127
   PubMed Web of Science ®Google Scholar
• Mendes AC, Baran ET, Reis RL, Azevedo HS. Self-assembly in nature: using the principles of nature to create complex nanobiomaterials. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2013;5(6):582–612. doi:10.1002/wnan.1238
   PubMed Web of Science ®Google Scholar
• Ghadiri MR, Granja JR, Milligan RA, McRee DE, Khazanovich N. Self-assembling organic nanotubes based on a cyclic peptide architecture. Nature. 1993;366(6453):324–327. doi:10.1038/366324a0
   PubMed Web of Science ®Google Scholar
• Zhang S, Holmes T, Lockshin C, Rich A. Spontaneous assembly of a self-complementary oligopeptide to form a stable macroscopic membrane. Proc Natl Acad Sci U S A. 1993;90(8):3334–3338. doi:10.1073/pnas.90.8.3334
   PubMed Web of Science ®Google Scholar
• Das RP, Singh BG, Kunwar A. Preparation of a size selective nanocomposite through temperature assisted co-assembly of gelatin and pluronic F127 for passive targeting of doxorubicin. Biomater Sci. 2020;8(15):4251–4265. doi:10.1039/D0BM00725K
   PubMed Web of Science ®Google Scholar
• Qiao L, Yang H, Gao S, Li L, Fu X, Wei Q. Research progress on self-assembled nanodrug delivery systems. J Mater Chem B. 2022;10(12):1908–1922. doi:10.1039/D1TB02470A
   PubMed Web of Science ®Google Scholar
• Jiang Y, Wang X, Liu X, et al. Enhanced Antiglioma Efficacy of Ultrahigh Loading Capacity Paclitaxel Prodrug Conjugate Self-Assembled Targeted Nanoparticles. ACS Appl Mater Interfaces. 2017;9(1):211–217. doi:10.1021/acsami.6b13805
   PubMed Web of Science ®Google Scholar
• Karaosmanoglu S, Zhou M, Shi B, Zhang X, Williams GR, Chen X. Carrier-free nanodrugs for safe and effective cancer treatment. J Control Release off J Control Release Soc. 2021;329:805–832. doi:10.1016/j.jconrel.2020.10.014
   PubMed Web of Science ®Google Scholar
• Nguyen HN, Ullevig SL, Short JD, Wang L, Ahn YJ, Asmis R. Ursolic Acid and Related Analogues: triterpenoids with Broad Health Benefits. Antioxid Basel Switz. 2021;10(8):1161. doi:10.3390/antiox10081161
   PubMed Web of Science ®Google Scholar
• Khwaza V, Oyedeji OO, Aderibigbe BA. Ursolic Acid-Based Derivatives as Potential Anti-Cancer Agents: an Update. Int J Mol Sci. 2020;21(16):5920. doi:10.3390/ijms21165920
   PubMed Web of Science ®Google Scholar
• Chen X, Chen J, Li B, et al. PLGA-PEG-PLGA triblock copolymeric micelles as oral drug delivery system: in vitro drug release and in vivo pharmacokinetics assessment. J Colloid Interface Sci. 2017;490:542–552. doi:10.1016/j.jcis.2016.11.089
   PubMed Web of Science ®Google Scholar
• Prasad S, Yadav VR, Sung B, et al. Ursolic acid inhibits growth and metastasis of human colorectal cancer in an orthotopic nude mouse model by targeting multiple cell signaling pathways: chemosensitization with capecitabine. Clin Cancer Res off J Am Assoc Cancer Res. 2012;18(18):4942–4953. doi:10.1158/1078-0432.CCR-11-2805
   PubMed Web of Science ®Google Scholar
• Fan L, Zhang B, Xu A, et al. Carrier-Free, Pure Nanodrug Formed by the Self-Assembly of an Anticancer Drug for Cancer Immune Therapy. Mol Pharm. 2018;15(6):2466–2478. doi:10.1021/acs.molpharmaceut.8b00444
   PubMedGoogle Scholar
• Zheng J, Fan R, Wu H, et al. Directed self-assembly of herbal small molecules into sustained release hydrogels for treating neural inflammation. Nat Commun. 2020;11(1):3815. doi:10.1038/s41467-020-17712-5
   PubMed Web of Science ®Google Scholar
• Li J, Kuang Y, Gao Y, Du X, Shi J, Xu B. D-amino acids boost the selectivity and confer supramolecular hydrogels of a nonsteroidal anti-inflammatory drug (NSAID). J Am Chem Soc. 2013;135(2):542–545. doi:10.1021/ja310019x
   PubMed Web of Science ®Google Scholar
• Pappas CG, Shafi R, Sasselli IR, et al. Dynamic peptide libraries for the discovery of supramolecular nanomaterials. Nat Nanotechnol. 2016;11(11):960–967. doi:10.1038/nnano.2016.169
   PubMed Web of Science ®Google Scholar
• Brown TE, Anseth KS. Spatiotemporal hydrogel biomaterials for regenerative medicine. Chem Soc Rev. 2017;46(21):6532–6552. doi:10.1039/C7CS00445A
   PubMed Web of Science ®Google Scholar
• Luo Q, Jin Q, Su C, et al. Radiolabeled Rhein as Small-Molecule Necrosis Avid Agents for Imaging of Necrotic Myocardium. Anal Chem. 2017;89(2):1260–1266. doi:10.1021/acs.analchem.6b03959
   PubMed Web of Science ®Google Scholar
• Bian L, Gao M, Zhang D, et al. Synthesis and Biological Evaluation of Rhein-Based MRI Contrast Agents for in Vivo Visualization of Necrosis. Anal Chem. 2018;90(22):13249–13256. doi:10.1021/acs.analchem.8b01868
   PubMed Web of Science ®Google Scholar
• Liu J, Hu G, Xu R, et al. Rhein lysinate decreases the generation of β-amyloid in the brain tissues of Alzheimer’s disease model mice by inhibiting inflammatory response and oxidative stress. J Asian Nat Prod Res. 2013;15(7):756–763. doi:10.1080/10286020.2013.800972
   PubMed Web of Science ®Google Scholar
• Wang A, Jiang H, Liu Y, et al. Rhein induces liver cancer cells apoptosis via activating ROS-dependent JNK/Jun/caspase-3 signaling pathway. J Cancer. 2020;11(2):500–507. doi:10.7150/jca.30381
   PubMed Web of Science ®Google Scholar
• Jing KL, Zhen GG, Shen Y, Wu ZJ, fan RP. Encapsulation of Aconitine in Self-Assembled Licorice Protein Nanoparticles Reduces the Toxicity In Vivo. Nanoscale Res Lett. 2015;10(1):1–8. doi:10.1186/1556-276X-10-1
   PubMedGoogle Scholar
• Wang J, Zhao H, Zhi K, Yang X. Exploration of the Natural Active Small-Molecule Drug-Loading Process and Highly Efficient Synergistic Antitumor Efficacy. ACS Appl Mater Interfaces. 2020;12(6):6827–6839. doi:10.1021/acsami.9b18443
   PubMed Web of Science ®Google Scholar
• Tian X, Wang P, Li T, et al. Self-assembled natural phytochemicals for synergistically antibacterial application from the enlightenment of traditional Chinese medicine combination. Acta Pharm Sin B. 2020;10(9):1784–1795. doi:10.1016/j.apsb.2019.12.014
   PubMed Web of Science ®Google Scholar
• Chen S, Chen Z, Wang Y, et al. Targeted delivery of Chinese herb pair-based berberine/tannin acid self-assemblies for the treatment of ulcerative colitis. J Adv Res. 2022;40:263–276. doi:10.1016/j.jare.2021.11.017
   PubMed Web of Science ®Google Scholar
• Singh N, Kumar M, Miravet JF, Ulijn RV, Escuder B. Peptide-Based Molecular Hydrogels as Supramolecular Protein Mimics. Chem Weinh Bergstr Ger. 2017;23(5):981–993.
   Google Scholar
• Habibi N, Kamaly N, Memic A, Shafiee H. Self-assembled peptide-based nanostructures: smart nanomaterials toward targeted drug delivery. Nano Today. 2016;11(1):41–60. doi:10.1016/j.nantod.2016.02.004
   PubMed Web of Science ®Google Scholar
• Dehsorkhi A, Castelletto V, Hamley IW. Self-assembling amphiphilic peptides. J Pept Sci off Publ Eur Pept Soc. 2014;20(7):453–467.
   PubMed Web of Science ®Google Scholar
• Zhang L, Huang Y, Lindstrom AR, Lin TY, Lam KS, Li Y. Peptide-based materials for cancer immunotherapy. Theranostics. 2019;9(25):7807–7825. doi:10.7150/thno.37194
   PubMed Web of Science ®Google Scholar
• Eskandari S, Guerin T, Toth I, Stephenson RJ. Recent advances in self-assembled peptides: implications for targeted drug delivery and vaccine engineering. Adv Drug Deliv Rev. 2017;110-111:169–187. doi:10.1016/j.addr.2016.06.013
   PubMed Web of Science ®Google Scholar
• Wang Q, Jiang N, Fu B, Huang F, Liu J. Self-assembling peptide-based nanodrug delivery systems. Biomater Sci. 2019;7(12):4888–4911. doi:10.1039/C9BM01212E
   PubMed Web of Science ®Google Scholar
• Sis MJ, Webber MJ. Drug Delivery with Designed Peptide Assemblies. Trends Pharmacol Sci. 2019;40(10):747–762. doi:10.1016/j.tips.2019.08.003
   PubMed Web of Science ®Google Scholar
• Hsieh WH, Liaw J. Applications of cyclic peptide nanotubes (cPNTs). J Food Drug Anal. 2019;27(1):32–47. doi:10.1016/j.jfda.2018.09.004
   PubMed Web of Science ®Google Scholar
• Park JH, Kim HA, Park JH, Lee M. Amphiphilic peptide carrier for the combined delivery of curcumin and plasmid DNA into the lungs. Biomaterials. 2012;33(27):6542–6550. doi:10.1016/j.biomaterials.2012.05.046
   PubMed Web of Science ®Google Scholar
• Fu Y, Li B, Huang Z, Li Y, Yang Y. Terminal is important for the helicity of the self-assemblies of dipeptides derived from alanine. Langmuir ACS J Surf Colloids. 2013;29(20):6013–6017. doi:10.1021/la400910g
   PubMed Web of Science ®Google Scholar
• Tomasini C, Castellucci N. Peptides and peptidomimetics that behave as low molecular weight gelators. Chem Soc Rev. 2013;42(1):156–172. doi:10.1039/C2CS35284B
   PubMed Web of Science ®Google Scholar
• Zhang L, Wang X, Wang T, Liu M. Tuning soft nanostructures in self-assembled supramolecular gels: from morphology control to morphology-dependent functions. Small Weinh Bergstr Ger. 2015;11(9–10):64.
   PubMed Web of Science ®Google Scholar
• Rivas M, Del Valle LJ, Alemán C, Puiggalí J. Peptide Self-Assembly into Hydrogels for Biomedical Applications Related to Hydroxyapatite. Gels. 2019;5(1):14. doi:10.3390/gels5010014
   PubMed Web of Science ®Google Scholar
• Raza F, Zhu Y, Chen L, et al. Paclitaxel-loaded pH responsive hydrogel based on self-assembled peptides for tumor targeting. Biomater Sci. 2019;7(5):2023–2036. doi:10.1039/C9BM00139E
   PubMed Web of Science ®Google Scholar
• Wei W, Meng C, Wang Y, et al. The interaction between self - assembling peptides and emodin and the controlled release of emodin from in-situ hydrogel. Cells Nanomed Biotechnol. 2019;47(1):3961–3975. doi:10.1080/21691401.2019.1673768
   PubMed Web of Science ®Google Scholar
• Zhang X, Parekh G, Guo B, et al. Polyphenol and self-assembly: metal polyphenol nanonetwork for drug delivery and pharmaceutical applications. Future Drug Discov. 2019;1(1):FDD7. doi:10.4155/fdd-2019-0001
   Google Scholar
• Zhang X, Li Z, Yang P, et al. Polyphenol scaffolds in tissue engineering. Mater Horiz. 2021;8(1):145–167. doi:10.1039/D0MH01317J
   PubMed Web of Science ®Google Scholar
• Z J, L Z, J Y, Ma R, Jj R, C F. Polyphenol-Mediated Assembly for Particle Engineering. Acc Chem Res. 2020;53(7):45.
   Web of Science ®Google Scholar
• Li Q, Dong Z, Chen M, Feng L. Phenolic molecules constructed nanomedicine for innovative cancer treatment. Coord Chem Rev. 2021;439:213912. doi:10.1016/j.ccr.2021.213912
   Web of Science ®Google Scholar
• Feng W, Shi W, Liu S, et al. Fe(III)-Shikonin Supramolecular Nanomedicine for Combined Therapy of Tumor via Ferroptosis and Necroptosis. Adv Healthc Mater. 2022;11(2):90.
   Web of Science ®Google Scholar
• Wen Y, Hu J, Liu J, Li M. Degradable Carrier-Free Metal–Phenolic Network Theranostic Agent with Targeted Mitochondrial Damage for Efficient Cancer Theranostics. Chem Mater. 2021;33(17):7089–7099. doi:10.1021/acs.chemmater.1c02267
   Web of Science ®Google Scholar
• Bertleff-Zieschang N, Arifur Rahim M, Ju Y, et al. Biofunctional metal–phenolic films from dietary flavonoids. Chem Commun. 2017;53(6):1068–1071. doi:10.1039/C6CC08607A
   Web of Science ®Google Scholar
• Li B, Shao H, Gao L, Li H, Sheng H, Zhu L. Nano-drug co-delivery system of natural active ingredients and chemotherapy drugs for cancer treatment: a review. Drug Deliv. 2022;29(1):2130–2161. doi:10.1080/10717544.2022.2094498
   PubMed Web of Science ®Google Scholar
• Wang M, Fu Y, Chen G, et al. Fabrication and characterization of carboxymethyl chitosan and tea polyphenols coating on zein nanoparticles to encapsulate β-carotene by anti-solvent precipitation method. Food Hydrocoll. 2018;77:577–587. doi:10.1016/j.foodhyd.2017.10.036
   Web of Science ®Google Scholar
• Shi F, Zhao JH, Liu Y, Wang Z, Zhang YT, Feng NP. Preparation and characterization of solid lipid nanoparticles loaded with frankincense and myrrh oil. Int J Nanomed. 2012;7:2033–2043. doi:10.2147/IJN.S30085
   PubMed Web of Science ®Google Scholar
• Wu Y, Lv S, Li Y, et al. Co-delivery of dual chemo-drugs with precisely controlled, high drug loading polymeric micelles for synergistic anti-cancer therapy. Biomater Sci. 2020;8(3):949–959. doi:10.1039/C9BM01662G
   PubMed Web of Science ®Google Scholar
• Fumoto S, Nishida K. Co-delivery Systems of Multiple Drugs Using Nanotechnology for Future Cancer Therapy. Chem Pharm Bull (Tokyo). 2020;68(7):603–612. doi:10.1248/cpb.c20-00008
   Web of Science ®Google Scholar
• Al Bostami RD, Abuwatfa WH, Husseini GA. Recent Advances in Nanoparticle-Based Co-Delivery Systems for Cancer Therapy. Nanomater Basel Switz. 2022;12(15):2672. doi:10.3390/nano12152672
   Web of Science ®Google Scholar
• Tagde P, Najda A, Nagpal K, et al. Nanomedicine-Based Delivery Strategies for Breast Cancer Treatment and Management. Int J Mol Sci. 2022;23(5):2856. doi:10.3390/ijms23052856
   PubMed Web of Science ®Google Scholar
• Scioli Montoto S, Muraca G, Ruiz ME. Solid Lipid Nanoparticles for Drug Delivery: pharmacological and Biopharmaceutical Aspects. Front Mol Biosci. 2020;7:587997. doi:10.3389/fmolb.2020.587997
   PubMed Web of Science ®Google Scholar
• Rahman HS, Othman HH, Hammadi NI, et al. Novel Drug Delivery Systems for Loading of Natural Plant Extracts and Their Biomedical Applications. Int J Nanomed. 2020;15:2439–2483. doi:10.2147/IJN.S227805
   PubMed Web of Science ®Google Scholar
• Luo CF, Yuan M, Chen MS, et al. Pharmacokinetics, tissue distribution and relative bioavailability of puerarin solid lipid nanoparticles following oral administration. Int J Pharm. 2011;410(1–2):138–144. doi:10.1016/j.ijpharm.2011.02.064
   Google Scholar
• Rostami E, Kashanian S, Azandaryani AH, Faramarzi H, Dolatabadi JEN, Omidfar K. Drug targeting using solid lipid nanoparticles. Chem Phys Lipids. 2014;181:56–61. doi:10.1016/j.chemphyslip.2014.03.006
   PubMed Web of Science ®Google Scholar
• Bayón-Cordero L, Alkorta I, Arana L. Application of Solid Lipid Nanoparticles to Improve the Efficiency of Anticancer Drugs. Nanomater Basel Switz. 2019;9(3):474. doi:10.3390/nano9030474
   Web of Science ®Google Scholar
• Fathy Abd-Ellatef GE, Gazzano E, Chirio D, et al. Curcumin-Loaded Solid Lipid Nanoparticles Bypass P-Glycoprotein Mediated Doxorubicin Resistance in Triple Negative Breast Cancer Cells. Pharmaceutics. 2020;12(2):96. doi:10.3390/pharmaceutics12020096
   PubMed Web of Science ®Google Scholar
• Harish V, Tewari D, Mohd S, et al. Quality by Design Based Formulation of Xanthohumol Loaded Solid Lipid Nanoparticles with Improved Bioavailability and Anticancer Effect against PC-3 Cells. Pharmaceutics. 2022;14(11):2403. doi:10.3390/pharmaceutics14112403
   Web of Science ®Google Scholar
• Guo J, Xing X, Lv N, et al. Therapy for myocardial infarction: in vitro and in vivo evaluation of puerarin-prodrug and tanshinone co-loaded lipid nanoparticulate system. Biomed Pharmacother. 2019;120:109480. doi:10.1016/j.biopha.2019.109480
   PubMed Web of Science ®Google Scholar
• Wang L, Wang X, Shen L, et al. Paclitaxel and naringenin-loaded solid lipid nanoparticles surface modified with cyclic peptides with improved tumor targeting ability in glioblastoma multiforme. Biomed Pharmacother Biomedecine Pharmacother. 2021;138:111461. doi:10.1016/j.biopha.2021.111461
   Web of Science ®Google Scholar
• Stiepel RT, Duggan E, Batty CJ, Ainslie KM. Micro and nanotechnologies: the little formulations that could. Bioeng Transl Med. 2023;8(2):e10421. doi:10.1002/btm2.10421
   Web of Science ®Google Scholar
• Kumar G, Virmani T, Sharma A, Pathak K. Codelivery of Phytochemicals with Conventional Anticancer Drugs in Form of Nanocarriers. Pharmaceutics. 2023;15(3):889. doi:10.3390/pharmaceutics15030889
   Web of Science ®Google Scholar
• Taléns-Visconti R, Díez-Sales O, De julián-ortiz JV, Nácher A. Nanoliposomes in Cancer Therapy: marketed Products and Current Clinical Trials. Int J Mol Sci. 2022;23(8):4249. doi:10.3390/ijms23084249
   Web of Science ®Google Scholar
• Steichen SD, Caldorera-Moore M, Peppas NA. A review of current nanoparticle and targeting moieties for the delivery of cancer therapeutics. Eur J Pharm Sci off J Eur Fed Pharm Sci. 2013;48(3):416–427.
   PubMed Web of Science ®Google Scholar
• Kumar P, Huo P, Liu B. Formulation Strategies for Folate-Targeted Liposomes and Their Biomedical Applications. Pharmaceutics. 2019;11(8):381. doi:10.3390/pharmaceutics11080381
   PubMed Web of Science ®Google Scholar
• Nsairat H, Khater D, Sayed U, Odeh F, Al Bawab A, Alshaer W. Liposomes: structure, composition, types, and clinical applications. Heliyon. 2022;8(5):e09394. doi:10.1016/j.heliyon.2022.e09394
   PubMed Web of Science ®Google Scholar
• Li Z, Zhang Y, Zhu C, et al. Folic acid modified lipid-bilayer coated mesoporous silica nanoparticles co-loading paclitaxel and tanshinone IIA for the treatment of acute promyelocytic leukemia. Int J Pharm. 2020;586:119576. doi:10.1016/j.ijpharm.2020.119576
   PubMed Web of Science ®Google Scholar
• Zhu Y, Wang A, Zhang S, et al. Paclitaxel-loaded ginsenoside Rg3 liposomes for drug-resistant cancer therapy by dual targeting of the tumor microenvironment and cancer cells. J Adv Res. 2023;49:159–173. doi:10.1016/j.jare.2022.09.007
   PubMed Web of Science ®Google Scholar
• Perumal S. Polymer Nanoparticles: synthesis and Applications. Polymers. 2022;14(24):5449. doi:10.3390/polym14245449
   Web of Science ®Google Scholar
• Amgoth C, Phan C, Banavoth M, et al. Polymer Properties: functionalization and Surface Modified Nanoparticles. Role Novel Drug Delivery Vehicles Nanobiomed IntechOpen. 2019.
   Google Scholar
• Zielińska A, Carreiró F, Oliveira AM, et al. Polymeric Nanoparticles: production, Characterization. Toxicol Ecotoxicol Mol Basel Switz. 2020;25(16):3731.
   Google Scholar
• Truong NP, Whittaker MR, Mak CW, Davis TP. The importance of nanoparticle shape in cancer drug delivery. Expert Opin Drug Deliv. 2015;12(1):129–142. doi:10.1517/17425247.2014.950564
   PubMed Web of Science ®Google Scholar
• Khoshravan Azar L, Dadashpour M, Hashemi M, Zarghami N. Design and Development of Nanostructured Co Delivery of Artemisinin and Chrysin for Targeting hTERT Gene Expression in Breast Cancer Cell Line: possible Clinical Application in Cancer Treatment. Asian Pac J Cancer Prev APJCP. 2022;23(3):919–927. doi:10.31557/APJCP.2022.23.3.919
   Google Scholar
• Afsharzadeh M, Hashemi M, Mokhtarzadeh A, Abnous K, Ramezani M. Recent advances in co-delivery systems based on polymeric nanoparticle for cancer treatment. Cells Nanomed Biotechnol. 2018;46(6):1095–1110. doi:10.1080/21691401.2017.1376675
   PubMed Web of Science ®Google Scholar
• Alven S, Aderibigbe BA. Efficacy of Polymer-Based Nanocarriers for Co-Delivery of Curcumin and Selected Anticancer Drugs. Nanomater Basel Switz. 2020;10(8):1556. doi:10.3390/nano10081556
   Web of Science ®Google Scholar
• Yu G, Ning Q, Mo Z, Tang S. Intelligent polymeric micelles for multidrug co-delivery and cancer therapy. Cells Nanomed Biotechnol. 2019;47(1):1476–1487. doi:10.1080/21691401.2019.1601104
   PubMed Web of Science ®Google Scholar
• Kar A, Rout SR, Singh V, et al. Chapter 22 - Triblock polymeric micelles as an emerging nanocarrier for drug delivery. In: Kesharwani P, Greish K, editors. Polymeric Micelles for Drug Delivery. Woodhead Publishing Series in Biomaterials. Woodhead Publishing; 2022. 561–590.
   Google Scholar
• Perumal S, Atchudan R, Lee W. A Review of Polymeric Micelles and Their Applications. Polymers. 2022;14(12):2510. doi:10.3390/polym14122510
   PubMed Web of Science ®Google Scholar
• Zhou L, Wu J, Sun Z, Wang W. Oxidation and Reduction Dual-Responsive Polymeric Prodrug Micelles Co-delivery Precisely Prescribed Paclitaxel and Honokiol for Laryngeal Carcinoma Combination Therapy. Front Pharmacol. 2022;13:934632. doi:10.3389/fphar.2022.934632
   PubMed Web of Science ®Google Scholar
• Maier-Hauff K, Ulrich F, Nestler D, et al. Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme. J Neurooncol. 2011;103(2):317–324. doi:10.1007/s11060-010-0389-0
   PubMed Web of Science ®Google Scholar
• Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021;20(2):101–124. doi:10.1038/s41573-020-0090-8
   PubMed Web of Science ®Google Scholar
• Sharma A, Goyal AK, Rath G. Recent advances in metal nanoparticles in cancer therapy. J Drug Target. 2018;26(8):617–632. doi:10.1080/1061186X.2017.1400553
   PubMed Web of Science ®Google Scholar
• Xu JJ, Zhang WC, Guo YW, Chen XY, Zhang YN. Metal nanoparticles as a promising technology in targeted cancer treatment. Drug Deliv. 2022;29(1):664–678. doi:10.1080/10717544.2022.2039804
   PubMed Web of Science ®Google Scholar
• Canese R, Vurro F, Marzola P. Iron Oxide Nanoparticles as Theranostic Agents in Cancer Immunotherapy. Nanomater Basel Switz. 2021;11(8):1950. doi:10.3390/nano11081950
   Web of Science ®Google Scholar
• Hiremath CG, Heggnnavar GB, Kariduraganavar MY, Hiremath MB. Co-delivery of paclitaxel and curcumin to foliate positive cancer cells using Pluronic-coated iron oxide nanoparticles. Prog Biomater. 2019;8(3):155–168. doi:10.1007/s40204-019-0118-5
   PubMed Web of Science ®Google Scholar